You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 19, 2025

Profile for Philippines Patent: 12015500915


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Philippines Patent: 12015500915

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,286,034 Nov 5, 2033 Cosette VYLEESI (AUTOINJECTOR) bremelanotide acetate
9,352,013 Nov 5, 2033 Cosette VYLEESI (AUTOINJECTOR) bremelanotide acetate
9,700,592 Nov 5, 2033 Cosette VYLEESI (AUTOINJECTOR) bremelanotide acetate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape of Philippines Patent PH12015500915

Last updated: August 7, 2025


Introduction

Philippines patent PH12015500915 pertains to a pharmaceutical invention filed within the country’s patent system. Analyzing its scope, claims, and the patent landscape offers insights for stakeholders—including companies, legal professionals, and researchers—regarding the patent’s strength, breadth, potential challenges, and its positioning within the broader pharmaceutical patent ecosystem.


Patent Overview

Patent Number: PH12015500915
Filing and Grant Date: Filed in 2015, granted in 2015 (or subsequent relevant date, depending on the official record).
Patent Assignee: Details depend on patent documents, potentially held by a pharmaceutical company or research institution.
Invention Title: Typically, a concise description is provided, such as a "Novel pharmaceutical composition" or "Method of manufacturing a drug."

Since the specific patent document details, including abstract and claims, are crucial, this analysis assumes access to the official patent database or patent document. For this exercise, the focus will be on typical patent claim constructs within the pharmaceutical realm.


Scope of Patent PH12015500915

The scope of a patent hinges on claim language and specification breadth. In pharmaceutical patents, scope often covers:

  • Compound Claims: Specific chemical entities or derivatives.
  • Formulation Claims: Composition-related claims covering combinations with excipients or stabilizers.
  • Method Claims: Processes for synthesizing, administering, or using the drug.
  • Use Claims: Therapeutic applications and indications.

Assuming PH12015500915 involves a chemical compound or composition, the scope likely encompasses:

  • The compound itself (if novel).
  • Pharmaceutical formulations containing the compound.
  • Methods of preparing the compound/formulation.
  • Therapeutic methods utilizing the compound.
  • Possible specific dosing regimens or delivery systems.

The scope is bounded by claim language, which determines the exclusivity zone.


Analysis of the Claims

Pharmaceutical patents typically have multiple claims arranged hierarchically, starting with broad independent claims and followed by narrower dependent claims.

Independent Claims

  • Core compound or composition: Usually claims to a chemical entity fulfilling certain structural criteria.
  • Method of use: Claims invoking a specific medical application, e.g., treatment of a disease.
  • Manufacturing process: Claims to synthetic pathways.

Example: A typical independent claim might read:

"A pharmaceutical composition comprising [chemical structure] and a pharmaceutically acceptable carrier, used for the treatment of [indication]."

Analysis:
Such a claim aims to secure broad coverage over the compound and use. Its strength depends on novelty, inventive step, and claim language clarity. If the structure closely mirrors existing compounds, the claim may be narrow, focusing on specific substituents or derivatives.

Dependent Claims

Dependent claims narrow the scope by incorporating specific features:

  • Specific salt forms or polymorphs.
  • Particular dosing routes or forms (e.g., tablet, injectable).
  • Combinations with other medications.
  • Specific manufacturing parameters.

Impact:
Dependent claims bolster patent robustness by covering variants, aiding enforcement against infringing parties.


Patent Landscape in the Philippines

The Philippines’s patent landscape in the pharmaceutical sector is characterized by:

  • Protection of Original Innovation: The country recognizes patents for novel chemical entities, formulations, and methods.
  • Worldwide Trends: The Philippines aligns with international standards under the Patent Cooperation Treaty (PCT) and TRIPS Agreement, ensuring framework consistency.
  • Generic Competition: Local generics companies often seek patent challenges or work around patents, emphasizing the importance of comprehensive claims.

Positioning of PH12015500915:
Without specific details, the patent’s strength hinges on its novelty and inventive step over prior art. The Philippine patent office (IPOPHL) applies stringent examinations but also faces challenges common in developing countries, like limited local prior art.


Legal and Patentability Considerations

  • Novelty: The invention must be new within the Philippine territory; prior art exists if identical compounds or methods are publicly disclosed elsewhere.
  • Inventive Step: Must differ significantly from existing technology; minor modifications generally fail unless non-obvious.
  • Utility: The invention must demonstrate some practical application.
  • Scope Compatibility: Broad claims increase enforceability but risk invalidation if too encompassing or obvious.

In practice, a patent like PH12015500915 must demonstrate distinctiveness over prior art, especially existing molecules, formulations, or methods in global patent databases (such as USPTO, EPO, or WIPO).


Challenges and Opportunities

  • Patent Cliffs: As patents expire, generic entry can erode exclusivity.
  • Patent Oppositions/Challenges: Competitors may challenge the patent’s validity, especially if claims are broad.
  • Pink Sheet Data and Clinical Data: The presence of clinical data supporting inventive step can fortify patent claims.
  • Local Regulatory Environment: Philippine regulatory approval processes influence commercial deployment but do not affect patent scope formally.

Opportunities stem from strong claim drafting, strategic use of patent families, and leveraging the patent for market and licensing strategies.


Comparison with Global Patent Landscape

In a global context, chemistry and pharmaceutical patents often face challenges based on prior art searches. Analyzing this patent in relation to:

  • World Patents: The US, Europe, and Asian jurisdictions.
  • Patent Families: Whether similar patents exist elsewhere.
  • Patent Litigation and Patent Landscaping Reports: These reports reveal the strength or vulnerability of the patent.

The Philippines’s patent system is generally harmonized with international standards but has a smaller duration and enforcement scope compared to patent-heavy jurisdictions like the US or Europe.


Conclusion

The Philippines patent PH12015500915 appears to be a carefully crafted pharmaceutical patent likely aiming for broad coverage over a novel compound, composition, or method. Its legal strength relies heavily on the specificity of its claims, novelty, and inventive step over existing prior art. Given the complex nature of pharmaceutical patent landscapes worldwide, comprehensive prior art searches and strategic claim drafting remain essential for maximizing patent protections and commercial leverage in the Philippines.


Key Takeaways

  • The patent’s scope is primarily defined by its claims, which should balance breadth with patentability.
  • Broad claims provide extensive coverage but are at higher risk of invalidation if challenged.
  • The Philippine patent landscape is aligned with international standards, yet local nuances influence enforcement.
  • A detailed prior art assessment is vital to confirm patent novelty and inventive step.
  • Strategic patenting, including claim narrowing and filing internationally, enhances market protection and licensing prospects.

FAQs

1. How does Philippine patent law define patentable pharmaceutical inventions?
Philippine patent law requires pharmaceutical inventions to be novel, involve an inventive step, and be industrially applicable. The invention must also not fall under exclusions such as discoveries, scientific theories, or mere discoveries of natural substances.

2. Can existing drugs be patented in the Philippines?
Existing drugs may only be patented if the invention pertains to a new use, formulation, method of manufacturing, or a novel derivative not disclosed in prior art, satisfying patentability criteria.

3. How does claim scope affect patent enforceability in the Philippines?
Broader claims increase market coverage but risk being challenged for lack of novelty or inventive step. Narrower claims, while easier to defend, limit exclusivity.

4. What are common challenges in enforcing pharmaceutical patents in the Philippines?
Patent infringement enforcement can be challenged by local generic manufacturers, patent invalidation proceedings, or lack of resources for litigation.

5. How does the patent landscape impact drug pricing and access in the Philippines?
Strong patent protections can delay generic entry, maintaining higher drug prices, which influences affordability and access. Conversely, patent challenges or filing for compulsory licenses may promote generic competition.


References:

  1. Philippine Intellectual Property Office (IPOPHL) Patent Search Database
  2. Philippine Patent Law (Republic Act No. 8293, AS amended)
  3. WIPO Patent Landscape Reports
  4. International Patent Application Resources

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.